These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 30298794)

  • 1. Identifying treatment responders using counterfactual modeling and potential outcomes.
    Porcher R; Jacot J; Wunder JS; Biau DJ
    Stat Methods Med Res; 2019; 28(10-11):3346-3362. PubMed ID: 30298794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies.
    Austin PC; Stuart EA
    Stat Med; 2015 Dec; 34(28):3661-79. PubMed ID: 26238958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimating the Optimal Personalized Treatment Strategy Based on Selected Variables to Prolong Survival via Random Survival Forest with Weighted Bootstrap.
    Shen J; Wang L; Daignault S; Spratt DE; Morgan TM; Taylor JMG
    J Biopharm Stat; 2018; 28(2):362-381. PubMed ID: 28934002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selection of the optimal personalized treatment from multiple treatments with multivariate outcome measures.
    Siriwardhana C; Datta S; Kulasekera KB
    J Biopharm Stat; 2020 May; 30(3):462-480. PubMed ID: 31691633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Causal inference in randomized experiments with mediational processes.
    Jo B
    Psychol Methods; 2008 Dec; 13(4):314-36. PubMed ID: 19071997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Causal effect models for realistic individualized treatment and intention to treat rules.
    van der Laan MJ; Petersen ML
    Int J Biostat; 2007; 3(1):Article 3. PubMed ID: 19122793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Personalized treatment selection via product partition models with covariates.
    Pedone M; Argiento R; Stingo FC
    Biometrics; 2024 Jan; 80(1):. PubMed ID: 38364806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of subpopulations with distinct treatment benefit rate using the Bayesian tree.
    Shen C; Hu Y; Li X; Wang Y; Chen PS; Buxton AE
    Biom J; 2016 Nov; 58(6):1357-1375. PubMed ID: 27356196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sharp bounds on the relative treatment effect for ordinal outcomes.
    Lu J; Zhang Y; Ding P
    Biometrics; 2020 Jun; 76(2):664-669. PubMed ID: 31742664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A likely responder approach for the analysis of randomized controlled trials.
    Laska E; Siegel C; Lin Z
    Contemp Clin Trials; 2022 Mar; 114():106688. PubMed ID: 35085831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Landmark estimation of survival and treatment effects in observational studies.
    Parast L; Griffin BA
    Lifetime Data Anal; 2017 Apr; 23(2):161-182. PubMed ID: 26880366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of principal scores to estimate the marginal compliers causal effect of an intervention.
    Porcher R; Leyrat C; Baron G; Giraudeau B; Boutron I
    Stat Med; 2016 Feb; 35(5):752-67. PubMed ID: 26381261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Instrumental variables and inverse probability weighting for causal inference from longitudinal observational studies.
    Hogan JW; Lancaster T
    Stat Methods Med Res; 2004 Feb; 13(1):17-48. PubMed ID: 14746439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing Heterogeneity of Treatment Effects in Observational Studies.
    Robertson SE; Leith A; Schmid CH; Dahabreh IJ
    Am J Epidemiol; 2021 Jun; 190(6):1088-1100. PubMed ID: 33083822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double robust estimation of optimal partially adaptive treatment strategies: An application to breast cancer treatment using hormonal therapy.
    Talbot D; Moodie EEM; Diorio C
    Stat Med; 2023 Jan; 42(2):178-192. PubMed ID: 36408723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiplicity-adjusted semiparametric benefiting subgroup identification in clinical trials.
    Schnell PM; Müller P; Tang Q; Carlin BP
    Clin Trials; 2018 Feb; 15(1):75-86. PubMed ID: 29035083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced precision in the analysis of randomized trials with ordinal outcomes.
    Díaz I; Colantuoni E; Rosenblum M
    Biometrics; 2016 Jun; 72(2):422-31. PubMed ID: 26576013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A probability based method for selecting the optimal personalized treatment from multiple treatments.
    Siriwardhana C; Zhao M; Datta S; Kulasekera KB
    Stat Methods Med Res; 2019 Mar; 28(3):749-760. PubMed ID: 29145777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Joint modeling of concurrent binary outcomes in a longitudinal observational study using inverse probability of treatment weighting for treatment effect estimation.
    Agogo GO; Murphy TE; McAvay GJ; Allore HG
    Ann Epidemiol; 2019 Jul; 35():53-58. PubMed ID: 31085069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defining responders to therapies by a statistical modeling approach applied to randomized clinical trial data.
    Bovis F; Carmisciano L; Signori A; Pardini M; Steinerman JR; Li T; Tansy AP; Sormani MP
    BMC Med; 2019 Jun; 17(1):113. PubMed ID: 31208412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.